Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma

Nina Obad, Heidi Espedal, Radovan Jirik, Per Oystein Sakariassen, Cecilie Brekke Rygh, Morten Lund-Johansen, Torfinn Taxt, Simone P. Niclou, Rolf Bjerkvig, Olivier Keunen*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

Neo-angiogenesis represents an important factor for the delivery of oxygen and nutrients to a growing tumour, and is considered to be one of the main pathodiagnostic features of glioblastomas (GBM). Anti-angiogenic therapy by vascular endothelial growth factor (VEGF) blocking agents has been shown to lead to morphological vascular normalisation resulting in a reduction of contrast enhancement as seen by magnetic resonance imaging (MRI). Yet the functional consequences of this normalisation and its potential for improved delivery of cytotoxic agents to the tumour are not known. The presented study aimed at determining the early physiologic changes following bevacizumab treatment. A time series of perfusion MRI and hypoxia positron emission tomography (PET) scans were acquired during the first week of treatment, in two human GBM xenograft models treated with either high or low doses of bevacizumab. We show that vascular morphology was normalised over the time period investigated, but vascular function was not improved, resulting in poor tumoural blood flow and increased hypoxia.

Original languageEnglish
Pages (from-to)1741-1753
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume38
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • Angiogenesis
  • VEGF
  • bevacizumab
  • glioblastoma
  • hypoxia
  • perfusion

Fingerprint

Dive into the research topics of 'Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma'. Together they form a unique fingerprint.

Cite this